|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Cash and due from banks | ||||||||||||||||
| Restricted cash (amounts related to VIEs of $6.3 million and $6.3 million, respectively) | ||||||||||||||||
| Interest bearing deposits in banks | ||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||
| Debt securities available-for-sale, at fair value | ||||||||||||||||
| Loans HFS, at fair value | ||||||||||||||||
| Loans HFS, at LCM | ||||||||||||||||
| Loans HFI, at fair value | ||||||||||||||||
| Loans held for investment, at amortized cost, net of deferred fees and costs | ||||||||||||||||
| Loans held for investment, at amortized cost, net | ||||||||||||||||
| Loans HFI, at amortized cost, net of deferred fees and costs | ||||||||||||||||
| Allowance for credit losses | ||||||||||||||||
| Loans HFI, at amortized cost, net | ||||||||||||||||
| Federal Home Loan Bank and Federal Reserve Bank stock | ||||||||||||||||
| Settlement receivable | ||||||||||||||||
| Residuals in securitizations, at fair value | ||||||||||||||||
| Joint ventures and other investments, at fair value (cost of $36,294 and $36,692), respectively | ||||||||||||||||
| Joint Ventures | ||||||||||||||||
| Controlled Investments | ||||||||||||||||
| Non-Control Investments | ||||||||||||||||
| Joint Ventures and Other Investments | ||||||||||||||||
| Goodwill and intangibles | ||||||||||||||||
| Right of use assets | ||||||||||||||||
| Derivative instruments | ||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||
| Servicing assets | ||||||||||||||||
| Servicing assets, at fair value | ||||||||||||||||
| Servicing assets, at LCM | ||||||||||||||||
| Total servicing assets | ||||||||||||||||
| Other assets | ||||||||||||||||
| Assets held for sale | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Deposits: | ||||||||||||||||
| Noninterest-bearing | ||||||||||||||||
| Interest-bearing | ||||||||||||||||
| Total deposits | ||||||||||||||||
| Borrowings (including borrowings of VIEs of $96.4 million and $127.1 million, respectively) | ||||||||||||||||
| Derivative instruments | ||||||||||||||||
| Dividends payable | ||||||||||||||||
| Lease liabilities | ||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||
| Due to participants | ||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||
| Liabilities directly associated with assets held for sale | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||
| Series B Preferred stock (par value $0.02 per share; 54 authorized, 50 issued and outstanding) | ||||||||||||||||
| Series A Preferred stock | ||||||||||||||||
| Series B Preferred stock | ||||||||||||||||
| Total series B Preferred stock (par value $0.02 per share; 54 authorized, 50 issued and outstanding) | ||||||||||||||||
| Common stock (par value $0.02 per share; 199,946 authorized, 28,892 and 28,658 issued and outstanding, respectively) | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated other comprehensive loss, net of income taxes | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...